- JP-listed companies
- SymBio Pharmaceuticals Limited
- Income statement
SymBio Pharmaceuticals Limited【JP:4582】Income statement
Market cap
¥4.4B
P/E ratio
-0.9x
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 1,883 | 1,955 | 1,532 | 1,955 | 1,933 | 2,368 | 3,444 | 3,836 | 2,838 | 2,987 | 8,257 | 10,008 | 5,590 | 2,453 |
| Cost of revenue | - | - | - | - | - | - | - | - | - | - | 2,452 | 2,408 | 1,179 | 580 |
| Gross profit | - | - | - | 527 | 583 | 904 | 1,031 | 1,173 | 865 | 867 | 5,804 | 7,600 | 4,411 | 1,873 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | -1,303 | -2,552 | -2,127 | -3,947 | -2,656 | -4,302 | -4,506 | 1,016 | 1,964 | -812 | -3,877 |
| Operating expenses | - | - | - | 1,830 | 3,135 | 3,031 | 4,978 | 3,829 | 5,166 | 5,373 | 4,784 | 5,636 | 5,223 | 5,750 |
| Income before tax | -2,095 | -1,729 | -1,601 | -1,110 | -2,630 | -2,317 | -3,977 | -2,749 | -4,377 | -4,616 | 1,001 | 2,000 | -736 | -3,689 |
| Provision for income taxes | - | - | - | 4 | 4 | 4 | 4 | 4 | 4 | 4 | -1,031 | 927 | 767 | 27 |
| Net income | -2,105 | -1,733 | -1,605 | -1,116 | -2,632 | -2,313 | -3,978 | -2,753 | -4,376 | -4,090 | 2,032 | 1,179 | -1,963 | -3,833 |
| Earnings per share | -143.6 | -90.6 | -69.29 | -36.26 | -81.26 | -58.82 | -79.78 | -41.38 | -189.03 | -124.13 | 53.04 | 30.2 | -49.19 | -85 |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | 52.32 | 29.77 | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |